Cambridge Healthtech Institute ’s 3rd Annual

Advances in Recovery and Purification

Optimizing DSP, Reducing Costs

25-26 March 2020


As product pipelines diversify away from traditional mAbs, downstream processing teams are under increasing pressure to develop new recovery and purification platforms for more complex products, such as bispecifics, ADCs, viral vectors, while at the same time reducing timelines, costs and bottlenecks for traditional mAbs therapies.

Cambridge Healthtech Institute’s Advances in Recovery and Purification conference brings together industry and academia to discuss the latest developments in the capture, recovery and purification of biotherapeutics – mAb and non-mAb – with data-driven case studies on next-generation technologies and strategies in affinity chromatography, clarification, depth filtration, automation, HTPD, new membranes, flocculation, as well as DSP strategies for emerging modalities, such as fragments, bispecifics, gene therapies and vaccines. How do your strategies compare?

Preliminary Agenda


Latest Challenges in Downstream Processing

Alois Jungbauer, PhD, Professor, Department of Biotechnology, University of Natural Resources Life Science, Vienna, Austria and Austrian Centre of Industrial Biotechnology

A Microfluidic Platform for Biopharmaceuticals Manufacturing Optimization

Raquel Aires-Barros, PhD, Professor, Bioengineering, Instituto Superior Técnico

Astonishing Features of Protein A Affinity Chromatography Resins

Rainer Hahn, PhD, Associate Professor, Department of Biotechnology, BOKU

Advances in Recovery and Purification

Cécile Brocard, PhD, Head, Downstream Process Development, Boehringer Ingelheim

Optimization of a Calcium-Dependent Protein Derived Domain for Mild Antibody Purification

Sophia Hober, PhD, Professor, School of Biotechnology, KTH-Royal Institute of Technology

Translating Legacy Downstream Batch Processes to Continuous, Including Clinical Scale Demonstration with Performance and Economic Analysis

Stuart Jamieson, PhD, Principal Scientist, Upstream, Downstream and Analytical, CPI Biologics

Design of a Periodic Counter-Current Chromatography Process for Efficient Oncolytic Virus Purification

Ricardo Silva, PhD, Scientist, Animal Cell Technology, iBET

How to Kill Your Complex Protein during Cell Removal and Strategies to Solve the Issue

Daniel Fleischanderl, Associate Director, Takeda


Strategies and Advances in Purification of New Therapeutic Modalities

Cristina Peixoto, PhD, Head, Downstream Processing Laboratory, IBET

Purification Considerations for Plasmid DNA to Enable Gene Therapies

Karolina Les, PhD, Scientist II, R&D Biopharmaceuticals, Purification Process Scientist, Astrazeneca

New Process Development for Purification of Novel D9k-Loop and D9k-Side Protein Scaffold Therapeutic Candidates

David O’Connell, PhD, Lecturer in Biotherapeutics, School of Biomolecular & Biomedical Science, University College Dublin

For more details on the conference, please contact:
Daniel Barry

Senior Conference Director

Cambridge Healthtech Institute

Phone: 781-247-6266



For partnering and sponsorship information, please contact:

Companies A-K

Sherry Johnson

Senior Business Development Manager

Cambridge Healthtech Institute

Phone: 781-972-1359



Companies L-Z

Carolyn Cooke

Business Development Manager

Cambridge Healthtech Institute

Phone: 781-972-5412